Skip to content
Trial Eligibility
Menu

Breast Re-irradiation After Second Ipsilateral Lumpectomy

NCT06867484

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Cancer
  • Cancer
  • Cancer of the Breast
  • HER2-negative Breast Cancer
  • ER+ Breast Cancer
  • Estrogen-receptor-positive Breast Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
40 years and older
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Youssef Zeidan
Last updated on ClinicalTrials.gov
November 13, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 2

  • Lynn Cancer Institute at Baptist Health, Inc. · Boca Raton, FL
  • Miami Cancer Institute at Baptist Health, Inc. · Miami, FL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.